Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$143M |
| 2 |
WNR
Western Refining Inc
WNR
|
+$142M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$137M |
| 4 |
BHI
Baker Hughes
BHI
|
+$135M |
| 5 |
POM
PEPCO HOLDINGS, INC.
POM
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$215M |
| 2 |
LSI
LSI CORPORATION
LSI
|
+$185M |
| 3 |
Omnicom Group
OMC
|
+$165M |
| 4 |
BRE
BRE PROPERTIES INC CL A
BRE
|
+$95M |
| 5 |
JOSB
JOS A BANK CLOTHIERS INC
JOSB
|
+$83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.95% |
| 2 | Technology | 13.55% |
| 3 | Financials | 10.47% |
| 4 | Energy | 10.33% |
| 5 | Industrials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEE.PRP
201
DELISTED
NEXTERA ENERGY INC EQUITY UNIT
NEE.PRP
| $46.4M | 0.13% |
812,775
+171,575
| +27% | +$9.55M |
|
202
Murphy USA
MUSA
$10.5B
| $46.1M | 0.12% |
942,747
+31,100
| +3% | +$1.44M |
|
203
Vertex Pharmaceuticals
VRTX
$139B
| $45.8M | 0.12% |
484,178
+29,200
| +6% | +$2.05M |
|
204
TIM SA
TIMB
$8.52B
| $45.6M | 0.12% |
1,571,535
+99,500
| +7% | +$2.72M |
|
205
United Therapeutics
UTHR
$22B
| $45.5M | 0.12% |
513,844
+103,000
| +25% | +$9.91M |
|
206
Banco Bradesco
BBD
$33.9B
| $45.4M | 0.12% |
7,970,973
+5,349,037
| +204% | +$31.3M |
|
207
Mondelez International
MDLZ
$82.3B
| $45.2M | 0.12% |
1,201,061
+382,300
| +47% | +$14M |
|
|
P
208
DELISTED
Pandora Media Inc
P
| $45.1M | 0.12% |
1,528,361
+245,200
| +19% | +$6.4M |
|
209
DuPont de Nemours
DD
$18.7B
| $44.7M | 0.12% |
343,378
+200,442
| +140% | +$25.5M |
|
210
Steel Dynamics
STLD
$32.8B
| $44.6M | 0.12% |
2,484,420
-22,946
| -0.9% | -$412K |
|
|
BBBY
211
DELISTED
Bed Bath & Beyond Inc
BBBY
| $44.6M | 0.12% |
776,790
+197,298
| +34% | +$12.3M |
|
|
ACAS
212
DELISTED
American Capital Ltd
ACAS
| $44.4M | 0.12% |
2,900,563
-387,800
| -12% | -$5.79M |
|
213
Murphy Oil
MUR
$5.36B
| $44.1M | 0.12% |
662,770
+109,400
| +20% | +$6.86M |
|
214
American Financial Group
AFG
$11.9B
| $44M | 0.12% |
738,774
+17,900
| +2% | +$1.04M |
|
215
Jabil
JBL
$32.8B
| $43.2M | 0.12% |
2,067,319
+180,600
| +10% | +$3.36M |
|
216
Keurig Dr Pepper
KDP
$43.6B
| $43.1M | 0.12% |
736,028
+306,400
| +71% | +$17.2M |
|
|
TFCF
217
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $43M | 0.12% |
1,256,456
+980,756
| +356% | +$32.5M |
|
218
Dover
DOV
$27.2B
| $42.8M | 0.12% |
582,715
+94,844
| +19% | +$6.63M |
|
219
Autodesk
ADSK
$53.6B
| $42.5M | 0.11% |
754,316
+378,900
| +101% | +$19.2M |
|
220
Dollar General
DG
$27.2B
| $42.4M | 0.11% |
739,946
+445,800
| +152% | +$25.5M |
|
|
APOL
221
DELISTED
Apollo Education Group Inc Class A
APOL
| $42M | 0.11% |
1,344,481
+493,805
| +58% | +$14.2M |
|
|
XLNX
222
DELISTED
Xilinx Inc
XLNX
| $41.6M | 0.11% |
878,344
+733,600
| +507% | +$35.3M |
|
223
eBay
EBAY
$46.3B
| $41.5M | 0.11% |
1,968,511
-244,728
| -11% | -$5.33M |
|
224
Goodyear
GT
$1.72B
| $41.3M | 0.11% |
1,486,950
+799,047
| +116% | +$20.9M |
|
225
Coca-Cola Europacific Partners
CCEP
$47.7B
| $41.1M | 0.11% |
859,582
| – | – |
|
Similar funds
Cliff Asness's Q2 2014 Portfolio in Review
As of Q2 2014, Cliff Asness held 2,714 positions worth $37.1B, up 12% from $33.1B the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
Cliff Asness's Q2 2014 filing shows 178 new, 1,030 increased, 953 reduced and 205 closed positions. Its largest new stake was AstraZeneca: 1,186,418 shares worth $88.2M. The largest sale was BEAM INC COM STK (DE), an estimated $215M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- Cliff Asness's largest Q2 2014 buy was AstraZeneca: 1,186,418 shares worth $88.2M.
- Cliff Asness added most to EOG Resources in Q2 2014, an estimated $143M increase.
- Cliff Asness's biggest Q2 2014 reduction was Omnicom Group, cutting an estimated $165M.
- Cliff Asness fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $215M.
- Cliff Asness's ten largest holdings make up 8.6% of its $37.1B portfolio in Q2 2014.
- Cliff Asness opened 178 new positions and closed 205 in Q2 2014.
- Cliff Asness's portfolio value rose 12% quarter-over-quarter to $37.1B.
Based on AQR Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.